Hemorrhagic Microangiopathy clinical trials at University of California Health

• Biomarkers of CASH

  Sorry, not currently recruiting here

  The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical clinical challenge in a disease affecting more than a million Americans. We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests a novel integrational approach of biomarker development in a mechanistically defined cerebrovascular disease, with a clinically relevant context of use.

  at UCSF

Last updated: July 8, 2020